Exosome: Emerging biomarker in breast cancer

Citations of this article
Mendeley users who have this article in their library.


Exosomes are nano-sized membrane vesicles released by a variety of cell types, and are thought to play important roles in intercellular communications. In breast cancer, through horizontal transfer of various bioactive molecules, such as proteins and mRNAs, exosomes are emerging as local and systemic cell-to-cell mediators of oncogenic information and play an important role on cancer progression. This review outlines the current knowledge and concepts concerning the exosomes involvement in breast cancer pathogenesis (including tumor initiation, invasion and metastasis, angiogenesis, immune system modulation and tumor microenvironment) and cancer therapy resistance. Moreover, the potential use of exosomes as promising diagnostic and therapeutic biomarkers in breast cancer are also discussed.




Jia, Y., Chen, Y., Wang, Q., Jayasinghe, U., Luo, X., Wei, Q., … Zhou, J. (2017). Exosome: Emerging biomarker in breast cancer. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.16684

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free